Supportive Care
Conditions
Keywords
Ultrasonography, Intravenous, Oncology
Brief summary
The purpose of this study is to investigate the clinical efficacy of nurse-performed ultrasound-guided intravenous access in oncology patients on the oncological outpatient unit in the National Hospital of the Faroe Islands.
Detailed description
This project is prospective, interventional, clinical study aligned in four different time stages. In the first stage, the pre-implementation stage, procedures are as usual, where the patient receives intravenous access via the use of the traditional palpation technique and data will be registered. In the next stage, the training stage, the nurses on the oncological outpatient unit will be trained in the use of the ultrasound-guided technique to place peripheral intravenous catheters and will be supervised by specialists in ultrasound. In the third stage, the implementation stage, the nurses will use the ultrasound technique as a daily routine in their practice. In the fourth stage, the post-implementation stage, the same data registration as in the first stage will be registered (see outcome measures) and the results will be compared in order to see the efficacy before and after implementation of ultrasound guidance. It is estimated a total sample of 100 cannulation procedures with approximately 30 patients needed in the pre-implementation and post-implementation stages.
Interventions
DEVICEUltrasound
Ultrasound-guided peripheral intravenous catheter insertion
Sponsors
National Hospital of the Faroe Islands
University of the Faroe Islands
University of Aarhus
Faroese Hospital System
Study design
Allocation
NON_RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)
Intervention model description
This is a before and after study, where the patients pre-implementation stage receive intravenous access via the traditional palpation technique and in the post-implementation stage receive ultrsound-guided intravenous cannulation.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Cancer patients admitted to the oncological outpatient unit are eligible for inclusion if they are scheduled for treatment with chemotherapy requiring placement of peripheral intravenous catheter, aged 18 years or older, and reside in the Faroe Islands.
Exclusion criteria
* Lack of informed consent and mental incapacity.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| First attempt success rate | The time frame for the outcome measure first attempt succes rate for each participant is estimated 1 hour in the pre-implementation stage and 1 hour in the post-implementation stage. | Placement of a functional peripheral intravenous catheter on the first attempt. Defined as retraction of the needle, blood in the plastic catheter, smooth insertion of the plastic catheter and subsequent flush with isotonic saline without signs of extravasal placement. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of skin punctures | The time frame for the outcome measure number of attempts for each participant is estimated 1 hour in the pre-implementation stage and 1 hour in the post-implementation stage. | Total number of insertion attempts i.e., number of skin punctures needed to successfully insert a peripheral intravenous catheter |
| Patient's satisfaction | The time frame for the outcome measure patient´s satisfaction for each participant is estimated 1 hour in the pre-implementation stage and 1 hour in the post-implementation stage. | Arbitrary Likert scale 0-5 |
| Patient's experience of pain | The time frame for the outcome measure patient´s experience of pain for each participant is estimated 1 hour in the pre-implementation stage and 1 hour in the post-implementation stage. | Numerical Rating Scale (NRS) scale 0-10 |
| Durability | The time frame for the outcome measure durability for each participant is estimated 4 hours in the pre-implementation stage and 4 hours in the post-implementation stage. | Is the chemotherpy session completed successfully (yes/no). Defined as intravenous chemotherapy successfully infused with only one peripheral intravenous catheter used. |
| Intravenous complications | The time frame for the outcome measure intravenous complications for each participant is estimated 4 hours in the pre-implementation stage and 4 hours in the post-implementation stage. | Intravenous complications such as e.g., infiltration, extravasation, vessel occlusion etc. |
Contacts
Primary ContactLisa Maria Anderssen, RN, MHS
Backup ContactMaria Skaalum Petersen, MSc, PhD
Outcome results
None listed